CClinicalTrials.gg
CompletedNCT06805968Updated Jul 17, 2026

Acute Exercise Intensity Responses in Women Who Smoke

An interventional study of High Intensity Exercise and Low Intensity Exercise in Smokers, sponsored by Istanbul Medipol University Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Sep 2023, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Cigarette smoking is associated with adverse cardiovascular, respiratory, and cognitive effects. Acute aerobic exercise may influence cardiovascular workload, respiratory function, and cognitive performance; however, evidence comparing the immediate effects of different exercise intensities in people who smoke remains limited. This randomized controlled trial investigated the immediate effects of a single high-intensity versus low-intensity treadmill exercise session on rate-pressure product, spirometric outcomes, and cognitive performance in female healthcare professionals working in special education settings who smoke. The study provides information on the immediate cardiovascular, respiratory, and cognitive responses to different intensities of treadmill exercise in this population.

Read the detailed description

Primary Objective To compare the immediate effects of a single high-intensity versus low-intensity treadmill exercise session on cardiovascular workload, as assessed by the baseline-to-postexercise change in rate-pressure product, in female healthcare professionals working in special education settings who smoke. Secondary Objectives To compare the immediate effects of a single high-intensity versus low-intensity treadmill exercise session on spirometric outcomes, including forced vital capacity, forced expiratory volume in 1 second, the FEV₁/FVC ratio, and peak expiratory flow, in female healthcare professionals working in special education settings who smoke. To compare the immediate effects of a single high-intensity versus low-intensity treadmill exercise session on cognitive performance, as assessed using the Stroop Test and the Montreal Cognitive Assessment, in female healthcare professionals working in special education settings who smoke. Study Questions Did a single high-intensity treadmill exercise session produce a greater immediate rate-pressure-product response than a single low-intensity treadmill exercise session in female healthcare professionals working in special education settings who smoke? Did the immediate changes in spirometric outcomes differ between the high-intensity and low-intensity treadmill exercise groups? Did the immediate changes in Stroop Test and Montreal Cognitive Assessment scores differ between the high-intensity and low-intensity treadmill exercise groups? Study Hypothesis It was hypothesized that high-intensity treadmill exercise would elicit a greater immediate rate-pressure-product response and different acute respiratory and cognitive responses than low-intensity treadmill exercise in female healthcare professionals working in special education settings who smoke.

02

Conditions studied

  • Smokers

Browse trials for

Keywords

  • smoker
  • aerobic
  • exercise
03

In context

Motor Activity

2,418 studies on the registry are indexed under Motor Activity; 1,162 are open to participants now.

This study's enrollment of 30 is below the median of 60 across 2,111 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Istanbul Medipol University Hospital is the lead sponsor of 350 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Current cigarette smoking, irrespective of nicotine dependence level
  • Voluntary agreement to participate in the study
  • Completion of the Fagerström Test for Nicotine Dependence
  • Absence of a known medical condition that would contraindicate treadmill exercise or interfere with cardiopulmonary assessment

Exclusion criteria

Exclusion Criteria:

  • Diagnosed cardiac or pulmonary disease
  • Orthopedic, neurological, vestibular, or systemic disease that could affect exercise performance
  • Use of bronchodilator medication
  • Orthopedic or cardiopulmonary surgery within the preceding year
  • Pregnancy
  • Clinically relevant sensory loss
  • Leg-length discrepancy that could affect exercise performance
  • Participation in another clinical study during the preceding month
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    high-intensity aerobic exercise group

    Other: High Intensity Exercise

  • Active comparator
    low-intensity aerobic exercise group

    Other: Low Intensity Exercise

Interventions

  • OtherHigh Intensity Exercise

    high intensity exercise

  • OtherLow Intensity Exercise

    low intensity exercise

06

What researchers measure

Primary outcomes

  1. Rate-Pressure Product (RPP)

    Rate-pressure product (RPP) is calculated by multiplying heart rate (beats/min) by systolic blood pressure (mmHg) and dividing the result by 100. RPP provides an index of myocardial oxygen demand and cardiac workload. There is no fixed minimum or maximum value. Higher RPP values indicate greater myocardial workload and oxygen consumption.

    Time frame: Duration of change in 1 day.

Secondary outcomes

  1. The Fagerström Test for Nicotine Dependence (FTND)

    The Fagerström Test for Nicotine Dependence (FTND) is a 6-item questionnaire used to assess the level of nicotine dependence. Total scores range from 0 to 10, with higher scores indicating greater nicotine dependence.

    Time frame: Duration of change in 1 day.

  2. Cognitive status measurement with MOCA

    The Montreal Cognitive Assessment (MoCA) is a screening tool used to assess global cognitive function, including attention, executive function, memory, language, visuospatial ability, abstraction, calculation, and orientation. Total scores range from 0 to 30, with higher scores indicating better cognitive function.

    Time frame: Duration of change in 1 day.

  3. Cognitive status measurement with Stroop Test

    The Stroop Test assesses selective attention, cognitive flexibility, and inhibitory control. The primary outcome is the completion time (seconds) required to complete the interference condition. There is no fixed minimum or maximum value. Shorter completion times indicate better cognitive performance, whereas longer completion times indicate poorer cognitive performance.

    Time frame: Duration of change in 1 day.

  4. FEV1 Measurement

    Respiratory Function Test. The COSMED microQuark spirometer used. Lung volume was evaluated. Forced Expiratory Volume in 1 Second (FEV₁) is measured using spirometry and represents the volume of air (liters) that can be forcibly exhaled during the first second of a forced expiration. There is no fixed minimum or maximum value. Higher FEV₁ values indicate better pulmonary function.

    Time frame: Duration of change in 1 day.

  5. FVC Measurement

    Respiratory Function Test. The COSMED microQuark spirometer used. Lung volume was evaluated. Forced Vital Capacity (FVC) is measured using spirometry and represents the total volume of air (liters) that can be forcibly exhaled after a maximal inspiration. There is no fixed minimum or maximum value. Higher FVC values indicate better pulmonary function.

    Time frame: Duration of change in 1 day.

07

Study locations

1 site
  • Istanbul Gedik University
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06805968
Lead sponsor
Istanbul Medipol University Hospital
Collaborators
Istanbul Gedik University
Responsible party
ebrar atak (Asst. Prof., Istanbul Medipol University Hospital) — Principal investigator
First posted
Feb 3, 2025
Start date
Sep 3, 2023
Primary completion
Dec 3, 2024
Completion
Nov 15, 2025
Last update
Jul 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion